Xavier Claramonte

752 total citations
15 papers, 494 citations indexed

About

Xavier Claramonte is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Xavier Claramonte has authored 15 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Xavier Claramonte's work include HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Xavier Claramonte is often cited by papers focused on HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Xavier Claramonte collaborates with scholars based in Spain, United States and Belgium. Xavier Claramonte's co-authors include Asunción Moreno, Estebán Martínez, José M. Miró, Manel Almela, Esteban Ribera, Francesc Marco, Jaime Cosín, Daniel Podzamczer, José M. Peña and Peré Domingo and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Xavier Claramonte

15 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Claramonte Spain 10 331 324 69 63 57 15 494
William J. Holloway United States 13 299 0.9× 318 1.0× 43 0.6× 65 1.0× 55 1.0× 29 581
Robert E. Levitz United States 10 113 0.3× 255 0.8× 43 0.6× 38 0.6× 15 0.3× 15 440
C. Cazorla France 10 200 0.6× 145 0.4× 131 1.9× 239 3.8× 57 1.0× 20 460
C Brandimarte Italy 8 114 0.3× 97 0.3× 90 1.3× 44 0.7× 92 1.6× 32 306
Ernö Gutschik Denmark 12 194 0.6× 282 0.9× 144 2.1× 84 1.3× 100 1.8× 29 414
Hanako Kurai Japan 11 114 0.3× 115 0.4× 53 0.8× 138 2.2× 69 1.2× 47 417
Madiha Fida United States 11 157 0.5× 206 0.6× 49 0.7× 59 0.9× 78 1.4× 45 400
Gretchen Rothrock United States 5 552 1.7× 457 1.4× 71 1.0× 24 0.4× 38 0.7× 9 659
T. May France 11 226 0.7× 191 0.6× 21 0.3× 29 0.5× 10 0.2× 57 421
Cunha Ba United States 12 98 0.3× 174 0.5× 62 0.9× 133 2.1× 27 0.5× 51 474

Countries citing papers authored by Xavier Claramonte

Since Specialization
Citations

This map shows the geographic impact of Xavier Claramonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Claramonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Claramonte more than expected).

Fields of papers citing papers by Xavier Claramonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Claramonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Claramonte. The network helps show where Xavier Claramonte may publish in the future.

Co-authorship network of co-authors of Xavier Claramonte

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Claramonte. A scholar is included among the top collaborators of Xavier Claramonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Claramonte. Xavier Claramonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sued, Omar, Juan Ambrosioni, David Nicolás, et al.. (2015). Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes. PLoS ONE. 10(7). e0131651–e0131651. 4 indexed citations
2.
Lejeune, Marylène, Elisa de Lazzari, Felipe García, et al.. (2011). Restoration of T Cell Responses to Toxoplasma gondii after Successful Combined Antiretroviral Therapy in Patients with AIDS with Previous Toxoplasmic Encephalitis. Clinical Infectious Diseases. 52(5). 662–670. 14 indexed citations
4.
Sued, Omar, José M. Miró, Aitor Alquézar, et al.. (2006). Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003). Enfermedades Infecciosas y Microbiología Clínica. 24(4). 238–244. 16 indexed citations
5.
Jimenez-Exposito, M.J., Carlos A. Mestres, Xavier Claramonte, et al.. (2006). Mortality and Morbidity in HIV-Infected Patients Undergoing Coronary Artery Bypass Surgery: a Case Control Study. Revista Española de Cardiología (English Edition). 59(3). 276–279. 12 indexed citations
6.
Jimenez-Exposito, M.J., Carlos A. Mestres, Xavier Claramonte, et al.. (2006). Morbimortalidad en pacientes con infección por el virus de la inmunodeficiencia humana que reciben cirugía de revascularización miocárdica: estudio de casos y controles. Revista Española de Cardiología. 59(3). 276–279. 8 indexed citations
8.
Jimenez-Exposito, M.J., Gerard Torres, Natividad Benito, et al.. (2004). Native Valve Endocarditis due toCandida glabrataTreated without Valvular Replacement: A Potential Role for Caspofungin in the Induction and Maintenance Treatment. Clinical Infectious Diseases. 39(7). e70–e73. 27 indexed citations
9.
Miró, José M., Ana del Rı́o, Felipe García, et al.. (2003). Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clinical Microbiology and Infection. 9(1). 45–54. 32 indexed citations
10.
Ribalta, Teresa, Julio A. Martinez, Pedro Jares, et al.. (2001). Presence of occult cytomegalovirus infection in the brain after orthotopic liver transplantation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 440(2). 166–171. 16 indexed citations
11.
Quirós, Juan Carlos López Bernaldo de, José M. Miró, José M. Peña, et al.. (2001). A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection. New England Journal of Medicine. 344(3). 159–167. 117 indexed citations
12.
Porta, F, et al.. (1997). [Antibiotic treatment of acute gastroenteritis].. PubMed. 197(4). 241–4. 1 indexed citations
13.
Moreno, Asunción, Josep Mensa, José M. Miró, et al.. (1994). Analysis of Factors Influencing the Outcome and Development of Septic Metastasis or Relapse in Salmonella Bacteremia. Clinical Infectious Diseases. 18(6). 873–878. 66 indexed citations
14.
Moreno, Asunción, Josep Mensa, Jordi Vilà, et al.. (1994). [Incidence of enteropathogens in patients with human immunodeficiency virus infection].. PubMed. 102(6). 205–8. 5 indexed citations
15.
Claramonte, Xavier, et al.. (1994). [Staphylococcus bovis infective endocarditis associated with gastric adenocarcinoma].. PubMed. 103(10). 397–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026